Professional Documents
Culture Documents
Orientation to Pharmacology
FOUR BASIC TERMS
DRUG A drug is defined as any chemical that can affect living processes. Virtually all chemicals can be considered drugs, since, when exposure is sufficiently high, all chemicals will have some effect on life.
Pharmacology. The study of drugs and their interactions with living systems.
Encompasses the study of the physical and chemical properties of drugs as well as their biochemical and physiologic effects
Pharmacology Includes knowledge of the history, sources, and uses of drugs knowledge of drug absorption, distribution, metabolism, and excretion
Includes the study of drugs in patients as well as in healthy volunteers (during new drug development).
Therapeutics. The use of drugs to diagnose, prevent, or treat disease or to prevent pregnancy. The medical use of drugs.
Administration
Dosage size and the route and timing of administration are important determinants of drug responses. Unfortunately, because of poor patient adherence and medication errors drugs are not always administered as prescribed. The result may be toxicity (if the dosage is too high) or treatment failure (if the dosage is too low).
Pharmacokinetics Pharmacokinetic processes determine how much of an administered dose gets to its sites of action. There are four major pharmacokinetic processes: Drug absorption, Drug distribution, Drug metabolism Drug excretion. These processes can be thought of as the impact of the body on drugs
Pharmacodynamics
Pharmacodynamic processes determine the nature and intensity of the response.
Pharmacodynamics can be thought of as the impact of drugs on the body. In most cases, the initial step leading to a response is the binding of a drug to its receptor.
APPLICATION OF PHARMACOLOGY IN
PATIENT CARE
Preadministration Assessment All drug therapy begins with assessment of the patient. Assessment has three basic goals: Collecting baseline data needed to evaluate therapeutic and adverse responses, Identifying high-risk patients, Assessing the patient's capacity for self-care.
Dosage and Administration Although you can implement the Five Rights without a detailed knowledge of pharmacology, having this knowledge can help reduce your contribution to medication errors.
Examples Certain drugs have more than one indication, and dosage may differ depending on which indication the drug is used for. Many drugs can be administered by more than one route, and dosage may differ depending upon the route selected
Evaluating Therapeutic Responses. In order to make an evaluation, you must know the rationale for treatment and the nature and time course of the intended response.
Promoting Patient Adherence ( Compliance ) If we are to achieve the therapeutic objective, adherence is essential By educating patients about the drugs they are taking, you can help elicit the required participation.
These include: Taking a thorough drug history Advising the patient to avoid over the counter drugs that can interact with the prescribed medication, Monitoring for adverse interactions known to occur between the drugs the patient is taking Being alert for as-yet unknown interactions.
Teaching . In your role as educator, you must give the patient the following information: Drug name and therapeutic category ( penicillin: antibiotic) Dosage size Dosing schedule
Teaching Route and technique of administration Expected therapeutic response and when it should develop Nondrug measures to enhance therapeutic responses Duration of treatment Method of drug storage
Teaching Symptoms of major adverse effects, and measures to minimize discomfort and harm Major adverse drug-drug and drug-food interactions Whom to contact in the event of therapeutic failure, severe adverse reactions, or severe adverse interactions
Drug Regulation
FDA
The origins of the Food and Drug Administration can be traced back to 1862, when President Lincoln appointed chemist Charles M. Wetherill to head the Chemical Division in the new U. S. Department of Agriculture. In the following decade Wetherill's successor as chief chemist of the USDA, Peter Collier, began working on the ubiquitous problem of food adulteration. Harvey W. Wiley replaced Collier in 1883, leading the division as it grew into the Bureau of Chemistry in 1901.
The bureau was charged to enforce the first comprehensive federal statute of its kind, the Federal Food and Drugs Act, when that law was passed in 1906.
Drug Regulation
Federal Pure Food and Drug Act of 1906.
The first American law to regulate drugs was the Federal Pure Food and Drug Act of 1906. It required only that drugs be free of adulterants. The law said nothing about drug safety or effectiveness.
Drug Regulation
Food, Drug and Cosmetic Act, 1938
First legislation to regulate drug safety Tragedy in which more than 100 people died following use of a new medication Congress required that all new drugs undergo testing for toxicity The results of these tests were to be reviewed by the Food and Drug Administration (FDA)
Drug Regulation Harris-Kefauver Amendments to the Food, Drug and Cosmetic Act 1962.
This law was created in response to the thalidomide tragedy that occurred in Europe in the early 1960s One of the bill's major provisions was to require proof of effectiveness before a new drug could be marketed. Remarkably, this was the first law to demand that drugs actually be of some benefit.
Drug Regulation
Harris-Kefauver Amendments to the Food, Drug and Cosmetic Act 1962.
The new act also required that all drugs that had been introduced between 1932 and 1962 undergo testing for effectiveness; any drug that failed to prove useful would be withdrawn. Established rigorous procedures for testing new drugs.
Meant to encourage pharmaceutical companies to develop drugs for diseases that have a small market Companies that develop such a drug (a drug for a disorder affecting fewer than 200,000 people in the United States) may sell it without competition for seven years,[2]
Some statistical burdens are lessened in an effort to maintain development momentum. For example, orphan drug regulations generally acknowledge the fact that it may not be possible to test 1,000 patients in a phase III clinical trial, as fewer than that number may be afflicted with the disease in question.
The chemical name constitutes a description of a drug using the nomenclature of chemistry A drug's chemical name can be long and complex. Because of their complexity, chemical names are inappropriate for everyday use
Drug Names
Trade Name
Trade names, also known as proprietary or brand names, are the names under which a drug is marketed. These names are created by drug companies with the intention that they be easy for nurses, physicians, pharmacists, and consumers to recall and pronounce. Since any drug can be marketed in different formulations and by multiple companies, the number of trade names that a drug can have is large.
Drug Names
Trade Name
Trade names must be approved by the FDA. The review process tries to ensure that no two trade names are too similar. Trade names cannot imply unlikely efficacy
Drug Classifications
Pharmacologic- Actions Mechanism of Action Therapeutic--- What they are used for
Pharmacokinetics
Definition : The term pharmacokinetics is derived from two Greek words: pharnakon (drug or poison) and kinesis (motion). As this derivation implies, pharmacokinetics is the study of drug movement throughout the body
Pharmacokinetics
Four Basic Pharmacokinetic processes: Absorption Distribution Metabolism Excretion The four processes determine the Concentration of drug at its site of action
Pharmacokinetics
Application
Absorption
Absorption is the movement of a drug from its site of administration into the blood. The rate of absorption determines how soon effects will begin. The amount of absorption helps determine how intense effects will be.
Absorption
Factors Affecting Drug Absorption Rate of Dissolution Surface Area Blood Flow Lipid Solubility PH Partitioning
Absorption
The routes of administration that are used most commonly fall into two major groups: Enteral (via the gastrointestinal tract) Parenteral. The literal definition of parenteral is outside the GI tract. The term parenteral is used to mean by injection. The principal parenteral routes are intravenous, subcutaneous, and intramuscular:
Absorption
Characteristics of Commonly Used Routes of Administration
Intravenous Barriers to Absorption. When a drug is administered IV, there are no barriers to absorption
Absorption Pattern Intravenous administration results in "absorption" that is both instantaneous and complete
IV Route Advantages. Rapid Onset Control. Use of Large Fluid Volumes . Use of Irritant Drugs
IV Route Disadvantages. High Cost, Difficulty, and Inconvenience. Irreversibility IV administration can be dangerous. Once a drug has been injected, there is no turning back;
Fluid Overload. When drugs are administered in a large volume, fluid overload can occur. This can be a significant problem for patients with hypertension, kidney disease, or heart failure. Infection. Infection can occur from injecting a contaminated drug. Embolism
Absorption Pattern. Drugs administered IM may be absorbed rapidly or slowly. The rate of absorption is determined largely by two factors: (1) water solubility of the drug (2) blood flow to the site of injection.
Advantages. The 1M route can be used for parenteral administration of poorly soluble drugs. tissue A second advantage of the 1M route is that we can administer depot preparations (preparations from which drug is absorbed slowly over an extended time).
Disadvantages. The major drawbacks of IM administration are discomfort and inconvenience. Intramuscular injection of some preparations can be painful. 1M injection can cause local tissue injury and possibly nerve damage (if njection is done improperly). Like all other forms of parenteral administration, IM injections are less convenient than oral administration.
Subcutaneous The pharmacokinetics of subQ administration are nearly identical to those of 1M administration. As with 1M administration, there are no significant barriers to absorption: Because of the similarities between subQ and 1M administration, these routes have similar advantages (suitability for poorly soluble drugs and depot preparations) and similar drawbacks (discomfort, inconvenience, potential for injury
Oral The abbreviation PO is used in reference to oral administration. This abbreviation stands for per as, a Latin phrase meaning by way of the mouth. Barriers to Absorption. Following oral administration, drugs may be absorbed from the stomach or intestine. : the layer of epithelial cells that lines the GI tract, capillary wall.
Because the walls of the capillaries that serve the GI tract offer no significant resistance to absorption, the major barrier to absorption is the GI epithelium. To cross this layer of tightly packed cells, drugs must pass through cells rather than between them.
Absorption Pattern. Factors that can influence absorption include 1) solubility and stability of the drug (2) gastric and intestinal pH (3) gastric emptying time (4) food in the gut (5) coadministration of other drugs (6) special coatings on the drug preparation.
Advantages. Oral administration is easy, convenient, and inexpensive Because of its relative ease, oral administration is the prefered route for selfmedication.
Disadvantages. Variability. The major disadvantage of PO therapy is that absorption can be highly variable. This variability makes it difficult to control the concentration of a drug at its sites of action, and Inactivation. Patient Requirements. Local Irritation.
DISTRIBUTION
Distribution is defined as the movement of drugs throughout the body. Drug distribution is determined by three major factors: Blood flow to tissues The ability of a drug to exit the vascular system The ability of a drug to enter cells.
Entering Cells
Some drugs must enter cells to reach their sites of action, Practically all drugs must enter cells to undergo metabolism and excretion. The factors that determine the ability of a drug to cross cell membranes are the same factors that determine the passage of drugs across all other membranes, namely, lipid solubility, the presence of a transport system, or both.
METABOLISM Known as biotransformation, is defined as the enzymatic alteration of drug structure. Most drug metabolism takes place in the liver.
Drug Metabolism
Therapeutic Consequences of Drug Metabolism
Drug metabolism has six possible consequences of therapeutic significance: Accelerated renal excretion of drugs Drug inactivation Increased therapeutic action Activation of "prodrugs" Increased toxicity Decreased toxicity
Drug Inactivation
. Drug metabolism can convert pharmacologically active compounds to inactive forms. This process is illustrated by the conversion of procaine (a local anesthetic) into paraaminobenzoic acid (PABA) an inactive metabolite
Activation of Prodrugs
. A prodrug is a compound that is pharmacologically inactive as administered and then undergoes conversion to its active form within the body. Activation of a prodrug is illustrated by the metabolic conversion of prazepam into desmethyldiazepam. Prazepam is a close relative of diazepam, a drug familiar to us under the trade name Valium.
EXCRETION
Drug excretion is defined as the removal of drugs from the body. Drugs and their metabolites can exit the body in urine, bile, Sweat, saliva, breast milk, and expired air. The most important organ for drug excretion is the kidney.
EXCRETION
Renal Drug Excretion The kidneys account for the majority of drug excretion. When the kidneys are healthy, they serve to limit the duration of action of many drugs. Renal failure - both the duration and intensity of drug responses may increase.
Plasma Concentrations
Minimum Effective Concentration The plasma drug level below which therapeutic effects will not occur Toxic Concentration. The plasma level at which toxic effects begin is termed the toxic concentration. Doses must be kept small enough so that the toxic concentration is not reached
Therapeutic Range
The objective of drug dosing is to maintain plasma drug levels within the therapeutic range.
The duration of effects is determined largely by the combination of metabolism and excretion. As long as drug levels remain above the MEC, therapeutic responses will be maintained
Drug Half-Life
The time required for the amount of drug in the body to decrease by 50% The half-life of a drug determines the dosing interval ( how much time separates each dose)
Pharmacodynamics
The study of the biochemical and physiologic effects of drugs and the molecular mechanisms by which those effects are produced. Pharmacodynamics is the study of what drugs do to the body and how they do it.
Maximal efficacy is defined as the largest effect that a drug can produce.
Transcription Factors
. Transcription factors differ from other receptors in two ways: (I) transcription factors are found within the cell rather than on the surrace, (2) responses to activation of these receptors are delayed.
Transcription Factors
Transcription factors are situated on DNA in the cell nucleus. Their function is to regulate protein synthesis. Activation of these receptors by endogenous ligands or by agonist drugs stimulates transcription of messenger RNA molecules, which then act as templates for synthesis of specific proteins.
Transcription Factors
Because transcription factors are intracellular, they can be activated only by ligands that are sufficiently lipid soluble to cross the cell membrane
Transcription Factors
Endogenous ligands that act through transcription factors include thyroid hormone and all of the steroid hormones ( progesterone, testosterone, cortisol).
EDso
EDso is an abbreviation for average effective dose. The ED so is defined as the dose that is required to produce a defined therapeutic response in 50% of the population. The EDso can be considered a "standard" dose and, as such, is frequently the dose selected for initial treatment.
Therapeutic Index
A large (or high) therapeutic index indicates that a drug is relatively safe.
Conversely, a small (or low) therapeutic index indicates that a drug is relatively unsafe.
Drug Interactions
Drug-drug interactions Drug-drug interactions can occur whenever a patient takes two or more drugs. Some interactions are both intended and desired, as when we combine drugs to treat hypertension
Drug Interactions
Drug interactions occur because patients frequently take more than one drug. They may take multiple drugs to treat a single disorder. They may have multiple disorders that require treatment with different drugs. They may take over-thecounter drugs in addition to prescription medicines. And they may take caffeine, nicotine, alcohol, and other drugs that have nothing to do with illness.
Intensification of Effects
When a patient is taking two medications, one drug may intensify the effects of the other. This type of interaction is often termed potentiative. Potentiative interactions may be beneficial or detrimental. A potentiative interaction that enhances therapeutic effects is clearly beneficial. Conversely, a potentiative interaction that intensifies adverse effects is clearly detrimental.
Reduction of Effects
Interactions that result in reduced drug effects are often termed inhibitory. As with potentiative interactions, inhibitory interactions can be beneficial or detrimental. Inhibitory inter actions that reduce toxicity are beneficial. Conversely, inhibitory interactions that reduce therapeutic effects are detrimental.
Pharmacokinetic Interactions
Drug interactions can affect all four of the basic pharmacokinetIc processes., when two drugs are taken together, one may alter the absorption, distribution, metabolism, or excretIon of the other.
Altered Distribution
There are two principal mechanisms by which one drug can alter the distribution of another: Competition for protein binding Alteration of extracellular pH.
Altered Metabolism
. Altered metabolism is one of the most important-and most complex-mechanisms by which drugs interact. Some drugs increase the metabolism of other drugs, and some drugs decrease the metabolism of other drugs.
Pharmacodynamic Interactions
Pharmacodynamic interactions are of two basic types: (1) interactions in which the interacting drugs act at the same site (2) interactions in which the interacting drugs act at separate sites Pharmacodynamic interactions may be potentiative or inhibitory, and are of great clinIcal significance
Pharmacodynamic Interactions
Interactions at the Same Receptor. Interactions that occur at the same receptor are almost always inhibitory.
Interactions Resulting from Actions at Separate Sites . Interactions resulting from effects produced at different sites may be potentiative or inhibitory.
Consequently, when these two drugs are administered together,the potassiumsparing effects of spironolactone tend to balance the potassium-wasting effects of hydrochlorothiazide, leaving renal excretion of potassium at about the same level it would have been had no drugs been given at all.
Combined Toxicity
DRUG-FOOD INTERACTIONS
Drug-food interactions are both important and poorly understood. They are important because they can result in toxicity or therapeutic failure. They are poorly understood because research has been sorely lacking.
DRUG-FOOD INTERACTIONS
Impact of Food on Drug Absorption Reducing the rate of absorption merely delays the onset of effects; peak effects are not lowered. In contrast, reducing the extent of absorption reduces the intensity of peak responses.
DRUG-FOOD INTERACTIONS
The interaction between calcium-containing foods and tetracycline antibiotics is perhaps the classic example of food reducing drug absorption. Tetracyclines bind with calcium to form an insoluble and nonabsorbable complex. Hence, if tetracyclines are administered with milk products or calcium supplements, absorption is reduced and antibacterial effects may be lost.
DRUG-FOOD INTERACTIONS
High-fiber foods can reduce absorption of some drugs. For example, absorption of digoxin [Lanoxin], a drug used for cardiac disorders, is reduced significantly by wheat bran, rolled oats, and sunflower seeds. Since digoxin has a low therapeutic index, reduced absorption can result in therapeutic failure
DRUG-HERB INTERACTIONS
Very few medications cause severe allergic reactions. In fact, most serious reactions are caused by just one drug family-the penicillins
Organ-Specific Toxicity
Hepatotoxic Drugs
Drugs are the leading cause of acute liver failure. Most cases end with a liver transplant or in death. The ability to cause severe liver damage is the most common reason for withdrawing an approved drug from the market.
MEDICATION ERRORS
Medication errors are a major cause of morbidity and mortality a medication error as "any preventable event that may cause or lead to inappropriate medication use or patient harm, while the medication is in the control of the healthcare professional, patient, or consumer.
MEDICATION ERRORS
Because the nurse is the last person who can catch mistakes made by others, and because no one is there to catch mistakes the nurse might make, the nurse bears a heavy responsibility for ensuring patient safety. Can you think of a better reason to learn all you can about drugs?
AGE
Drug sensitivity varies with age. In the very young, heightened drug sensitivity is the result of organ immaturity In the elderly, heightened sensitivity results largely from organ degeneration
PATHOPHYSIOLOGY
Abnormal physiology can alter responses to drugs
Kidney disease
Can reduce drug excretion, causing drugs to accumulate in the body. If dosage is not lowered, drugs may accumulate to toxic levels. Accordingly, if a patient is taking a drug that is eliminated by the kidneys, and if renal failure develops, dosage must be decreased.
Liver Disease
Like kidney disease, liver disease can cause drugs to accumulate. Recall that the liver is the major site of drug metabolism. Hence, if the liver ceases to function, rates of metabolism will fall and drug levels will climb. To prevent accumulation to toxic levels, patients with liver disease should have their dosages reduced.
Acid-Base Imbalance
By altering pH partitioning, changes in acidbase status can alter the absorption, distribution, metabolism, and excretion of drugs.
TOLERANCE
Tolerance can be defined as decreased responsiveness to a drug as a result of repeated drug administration. Patients who are tolerant to a drug require higher doses to produce effects equivalent to those that could be achieved with lower doses There are three categories of drug tolerance: Pharmacodynamic tolerance Metabolic tolerance
Pharmacodynamic Tolerance
Pharmacodynamic tolerance refers to the familiar type of tolerance associated with long-term administration of drugs such as morphine and heroin Pharmacodynamic tolerance is thought to result from adaptive processes that occur in response to chronic receptor occupation.
Metabolic Tolerance
Metabolic tolerance is defined as tolerance resulting from accelerated drug metabolism . This form of tolerance is brought about by the ability of certain drugs to induce synthesis of hepatic drug-metabolizing enzymes Because of increased metabolism, dosage must be increased to maintain therapeutic drug levels
Tachyphylaxis
Tachyphylaxis is a form of tolerance that can be defined as a reductic drug responsiveness brought on by repeated dosing over a short time. Unlike pharmacodynamic and metabolic tolerance, which take days to develop tachyphylaxis occurs quickly. Transdermal nitroglycerin provides a good example
Placebo Effect
In pharmacology, the placebo effect is defined as that component of a drug response that is caused by Psychologic factors and not by the biochemical or physiologic properties of the drug. Although it is impossible to assess with precision contribution that psychologic factors make to the overall response to any particular drug
VARIABILITY IN ABSORPTION
Both the rate and extent of drug absorption can vary among patients
Bioavailability
Refers to the ability of a drug to reach the systemic circulation from its site of administration. . Different preparations of the same drug can vary in bioavailability Such factors as tablet disintegration time, enteric coatings, and sustained-release formulations can alter bioavailability
Bioavailability
Differences in bioavailability are of greatest concern for drugs with a narrow therapeutic range.
GENETIC
A patient's unique genetic makeup can lead to drug responses that are qualitatively and quantitatively different from those of the population at large The major underlying causes of altered responses are alterations in genes that code for drug metabolizing enzymes and drug targets
GENDER
Men and women can respond differently to the same drug Alcohol is metabolized more slowly by women than by men. As a result, a woman who drinks the same amount as a man (on a weight-adjusted basis) will become more intoxicated .
GENDER
Certain opioid analgesics are much more effective in women than in men. As a result, pain relief can be achieved at lower doses in women
RACE
Race-related drug responses have two primary determinants: genetic variations and psychosocial factors
DIET
Starvation can reduce protein binding of drugs by decreasing the level of plasma albumin Because of reduced binding, levels of free drug rise, thereby making drug responses more intense.